Clinical Trial Update: Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Anti-T-Lymphocyte Globulin (ATG) in renal transplantation using kidneys from non-heart-beating donors. The current status is U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Anti-T-Lymphocyte Globulin (ATG) (anti-thymocyte globulin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Renal Transplant Patients, Recipients of a Kidney From a Non-Heart-Beating Donor | Phase 3 | Status: UNKNOWN